Gerald R. Ewoldt

Array ( [id] => 6846334 [patent_doc_number] => 20030165501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Treatment involving Dkk-1 or antagonists thereof' [patent_app_type] => new [patent_app_number] => 10/077065 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30477 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165501.pdf [firstpage_image] =>[orig_patent_app_number] => 10077065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6687931 [patent_doc_number] => 20030031656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response' [patent_app_type] => new [patent_app_number] => 10/072425 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17966 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031656.pdf [firstpage_image] =>[orig_patent_app_number] => 10072425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033109 [patent_doc_number] => 20050031618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Induction of tolerance by apoptotic and/or necrotic cells' [patent_app_type] => utility [patent_app_number] => 10/470536 [patent_app_country] => US [patent_app_date] => 2002-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7218 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031618.pdf [firstpage_image] =>[orig_patent_app_number] => 10470536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243684 [patent_doc_number] => 20050271674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Methods and compositions for modulating the immune system of animals' [patent_app_type] => utility [patent_app_number] => 10/470982 [patent_app_country] => US [patent_app_date] => 2002-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12586 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271674.pdf [firstpage_image] =>[orig_patent_app_number] => 10470982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682698 [patent_doc_number] => 20030118562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response' [patent_app_type] => new [patent_app_number] => 10/057514 [patent_app_country] => US [patent_app_date] => 2002-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17979 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118562.pdf [firstpage_image] =>[orig_patent_app_number] => 10057514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845274 [patent_doc_number] => 20020132772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Use of IGF-I or analogues thereof in the prevention of diabetes' [patent_app_type] => new [patent_app_number] => 10/050298 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4584 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132772.pdf [firstpage_image] =>[orig_patent_app_number] => 10050298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 508210 [patent_doc_number] => 07198948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Methods and compositions for obtaining mature dendritic cells' [patent_app_type] => utility [patent_app_number] => 10/047072 [patent_app_country] => US [patent_app_date] => 2002-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19395 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/198/07198948.pdf [firstpage_image] =>[orig_patent_app_number] => 10047072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985093 [patent_doc_number] => 20020098186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Use of endothelin inhibitors for treatment or prevention of fibrotic disorders' [patent_app_type] => new [patent_app_number] => 10/043317 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6171 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098186.pdf [firstpage_image] =>[orig_patent_app_number] => 10043317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575347 [patent_doc_number] => 07455984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Immunoreactive and immunotherapeutic molecules' [patent_app_type] => utility [patent_app_number] => 10/040815 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5470 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/455/07455984.pdf [firstpage_image] =>[orig_patent_app_number] => 10040815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750946 [patent_doc_number] => 20030045467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Autoantigen composition' [patent_app_type] => new [patent_app_number] => 10/038686 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14012 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045467.pdf [firstpage_image] =>[orig_patent_app_number] => 10038686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568028 [patent_doc_number] => 20020165186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds' [patent_app_type] => new [patent_app_number] => 10/025367 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18288 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165186.pdf [firstpage_image] =>[orig_patent_app_number] => 10025367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766086 [patent_doc_number] => 20030100486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes' [patent_app_type] => new [patent_app_number] => 10/017905 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15340 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100486.pdf [firstpage_image] =>[orig_patent_app_number] => 10017905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844411 [patent_doc_number] => 20020132342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Method for generating immortal dendritic cell lines' [patent_app_type] => new [patent_app_number] => 10/013587 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12289 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132342.pdf [firstpage_image] =>[orig_patent_app_number] => 10013587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6782966 [patent_doc_number] => 20030064413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Compositions and methods useful in avidity therapy' [patent_app_type] => new [patent_app_number] => 10/005917 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12784 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064413.pdf [firstpage_image] =>[orig_patent_app_number] => 10005917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5967332 [patent_doc_number] => 20020090371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Methods and products for controlling the immune responses in mammals' [patent_app_type] => new [patent_app_number] => 10/005073 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6739 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090371.pdf [firstpage_image] =>[orig_patent_app_number] => 10005073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688369 [patent_doc_number] => 20030032094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Isolated mammalian dendritic cell genes; related reagents' [patent_app_type] => new [patent_app_number] => 09/994444 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26449 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032094.pdf [firstpage_image] =>[orig_patent_app_number] => 09994444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852270 [patent_doc_number] => 20030144473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases' [patent_app_type] => new [patent_app_number] => 09/988165 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4353 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144473.pdf [firstpage_image] =>[orig_patent_app_number] => 09988165 [rel_patent_id] =>[rel_patent_doc_number] =>)